Latest News and Press Releases

Certara announced the launch of TFL Studio, the first cloud-native module of its Phoenix Cloud solution.

RADNOR, Pa., Oct. 31, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced that Company management will participate in the...

Certara today announced the launch of Certara IQ, a scalable, AI-powered Quantitative Systems Pharmacology (QSP) solution.

Certara celebrates its 200 published papers and 11 scientists on the Stanford/Elsevier top 2% cited researchers list in 2025.

RADNOR, Pa., Oct. 10, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it will release financial results for the third quarter of 2025...

Certara today announced the availability of Pinnacle 21 Enterprise Plus, the gold-standard clinical data validation engine.

RADNOR, Pa., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced that Company management will participate in the...

RADNOR, Pa., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today reported its financial results for the second quarter of fiscal...

Certara today announced that the European Medicines Agency has formally qualified the Simcyp® Simulator for use in regulatory submissions across the EU.

Certara appoints Dr. Chris Bouton as Chief Technology Officer to advance AI in-silico drug discovery and development platform.